SVS Management Ltd Pharmaceutical Import Profile — Poland (DGFT 2022–2026)

Name: SVS Management Ltd Pharmaceutical Import Records from India — 2 Products, $8.7K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

SVS Management Ltd — Pharmaceutical Importer Profile (2026) | 2 Products, $8.7K Trade | TransData Nexus

SVS Management Ltd

Pharmaceutical Importer · Poland · Ayurvedic & Herbal Products Focus · $8.7K Total Trade · DGFT Verified

SVS Management Ltd is a pharmaceutical importer based in Poland with a total trade value of $8.7K across 2 products in 1 therapeutic categories. Based on 13 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. SVS Management Ltd sources from 3 verified Indian suppliers, with Shri Dharmasthala Manjunatheshwara Baishajya Prati accounting for 48.7% of imports.

SVS Management Ltd — Import Portfolio & Supplier Network

SVS Management Ltd import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to SVS Management Ltd?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Shri Dharmasthala Manjunatheshwara Baishajya Prati	$45.2K	135	48.7%
Yaksha India Expo	$42.8K	80	46.0%
New Udaya Pharmacy & Ayurvedic Laboratories	$4.9K	18

What Formulations Does SVS Management Ltd Import?

Formulation	Value	Ships
Ayurvedic manasmithra vati 100	$5.1K	1
Shiva gutika , batch no-svt020 100 pills 780 ML pet container-36units x 9boxesmfg.date- 10/2023, exp. date- 09/2026	$2.9K	1
Shiva gutika batch no-svt015100 pills	$2.8K	1
Herbal ksheerbala tabs	$2.7K	1
Herbal mansa mithra	$2.3K	1
Herbal h-91	$1.9K	1
Ayurvedic ksheerbala CAPS	$1.9K	1
Ayurvedic	$1.8K	1
Ayurvedic liv up	$1.8K	1
Ashwagandha capsules , batch no-age057,100 tablets in milky white hdpe container - 100 units x 5 boxes mfg.date-	$1.8K	1
Ayurvedic manasmithra vati 50	$1.7K	1
Triphala tablets ds , batch no-tdt021 100 tablets in milky white hdpe container - 100 units x 10 boxes mfg.date-	$1.6K	1
Brahmi capsules , batch no-bme026 ,100capsules in milky white hdpe container- 100 units x 10boxes mfg.date- 12/2023	$1.5K	1
Triphala guggulu ds , batch no-tpt018 100 tablets in milky white hdpe container - 100 units x 5 boxes mfg.date-	$1.3K	1
Ayurvedic goutex	$1.3K	1

SVS Management Ltd imports 232 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Gutika	Ayurvedic & Herbal Products	$6.2K	4	4.9%	4
2	Ghrita	Ayurvedic & Herbal Products	$2.6K	9	0.6%	17

SVS Management Ltd imports 2 pharmaceutical products across 1 categories into Poland totaling $8.7K.

SVS Management Ltd — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

SVS Management Ltd is a pharmaceutical importer based in Poland, specializing in the acquisition of finished pharmaceutical formulations from India. The company has engaged in 13 shipments, importing two distinct products across a single therapeutic category, Ayurvedic & Herbal Products. The total import value from India amounts to $9,000 USD. The primary products imported include Gutika, valued at $6,000 USD, and Ghrita, valued at $3,000 USD. These products are sourced from three verified Indian suppliers: Shri Dharmasthala Manjunatheshwara Baishajya Prati, Yaksha India Expo, and New Udaya Pharmacy & Ayurvedic Laboratories. The company's operations are characterized by a high degree of supplier concentration, with the top five products accounting for 100% of the import portfolio. This suggests a focused approach to sourcing, potentially leveraging specialized supplier relationships to meet specific market demands in Poland.

2Distribution Network

While specific details regarding SVS Management Ltd's warehouse locations and logistics capabilities are not publicly disclosed, the company's import activities indicate a reliance on established distribution channels within Poland. The importation of Ayurvedic & Herbal Products from India suggests that the company may collaborate with local distributors or wholesalers to facilitate the storage and distribution of these products. Given the specialized nature of Ayurvedic products, it is likely that SVS Management Ltd partners with entities experienced in handling such goods, ensuring compliance with Polish regulations and meeting market demand.

3Industry Role

SVS Management Ltd functions as a pharmaceutical importer in Poland, focusing on the acquisition of finished pharmaceutical formulations from India. The company's import activities are concentrated in the Ayurvedic & Herbal Products category, indicating a niche market focus. By sourcing directly from Indian manufacturers, SVS Management Ltd plays a pivotal role in introducing and distributing these specialized products within the Polish pharmaceutical market. This positioning allows the company to cater to a specific consumer segment seeking Ayurvedic and herbal remedies, thereby contributing to the diversification of available pharmaceutical options in Poland.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — SVS Management Ltd

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

SVS Management Ltd's sourcing strategy exhibits a high degree of concentration, with the top five products accounting for 100% of the import portfolio. This indicates a focused approach to procurement, potentially aimed at maintaining strong supplier relationships and ensuring product consistency. The reliance on a limited number of suppliers—three verified Indian suppliers—suggests a strategic choice to streamline operations and possibly negotiate favorable terms. However, this concentration also introduces risks associated with supply chain disruptions, such as potential delays or quality issues from a single supplier. To mitigate these risks, it would be prudent for SVS Management Ltd to consider diversifying its supplier base and exploring additional product lines within the Ayurvedic & Herbal Products category.

2Supply Chain Resilience

The resilience of SVS Management Ltd's supply chain is closely tied to the stability and reliability of its Indian suppliers. The company's current sourcing strategy, characterized by a high degree of concentration, may expose it to risks associated with supply chain disruptions, such as delays or quality issues from a single supplier. To enhance supply chain resilience, it would be prudent for SVS Management Ltd to consider diversifying its supplier base and exploring additional product lines within the Ayurvedic & Herbal Products category. This approach would not only mitigate potential risks but also provide a broader range of products to meet the diverse needs of the Polish market.

Importing Pharmaceuticals into Poland — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Poland

1Regulatory Authority & Framework

In Poland, the Chief Pharmaceutical Inspectorate (Główny Inspektorat Farmaceutyczny, GIF) is the primary regulatory authority overseeing the manufacturing and import of medicinal products. According to the Pharmaceutical Law Act, activities related to the manufacture or import of medicinal products require authorization from the Chief Pharmaceutical Inspector. The GIF is responsible for issuing such authorizations and conducting inspections to ensure compliance with Good Manufacturing Practice (GMP) requirements. Additionally, the GIF supervises the protection and disposal of narcotics, psychotropic substances, and category 1 precursors, as stipulated in the Act on Prevention of Drug Abuse and related regulations. (archiwum.gif.gov.pl)

2Import Licensing & GMP

Importing medicinal products into Poland necessitates obtaining a license from the Chief Pharmaceutical Inspectorate. This license is granted based on compliance with the Pharmaceutical Law Act and associated regulations. The Chief Pharmaceutical Inspectorate conducts inspections to verify adherence to Good Manufacturing Practice (GMP) standards, ensuring that imported products meet quality, safety, and efficacy requirements. These inspections are typically conducted at least once every three years, with additional ad-hoc inspections possible if there are concerns about product quality or safety. (archiwum.gif.gov.pl)

SVS Management Ltd — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

SVS Management Ltd's focus on importing Ayurvedic & Herbal Products aligns with a growing consumer interest in alternative and natural remedies in Poland. The market demand for such products is driven by consumers seeking holistic health solutions and a preference for traditional medicine. By specializing in this niche, SVS Management Ltd can cater to a specific segment of the market, offering products that meet the unique needs and preferences of Polish consumers. This strategic focus allows the company to build expertise and establish a strong presence in the Ayurvedic & Herbal Products sector.

2Sourcing Profile

SVS Management Ltd's sourcing strategy is centered on importing finished pharmaceutical formulations from India, specifically within the Ayurvedic & Herbal Products category. This approach allows the company to leverage India's rich heritage in Ayurvedic medicine and access a diverse range of products. By focusing on finished formulations, SVS Management Ltd ensures that the products are ready for distribution and sale in the Polish market, streamlining the supply chain and reducing the time to market. This strategy also enables the company to maintain control over product quality and consistency, which is crucial in the pharmaceutical industry.

3Market Positioning

Seller's Guide — How to Become a Supplier to SVS Management Ltd

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to enter the Polish market through partnerships with SVS Management Ltd. The company's focused sourcing strategy indicates a potential openness to expanding its supplier base, especially if new suppliers can offer high-quality Ayurvedic & Herbal Products that meet Polish regulatory standards. Additionally, exploring additional product lines within the Ayurvedic & Herbal Products category could provide SVS Management Ltd with a more diverse portfolio, catering to a broader range of consumer preferences.

2Requirements & Qualifications

Indian exporters seeking to supply SVS Management Ltd and the Polish market must ensure that their products comply with Polish regulations, including obtaining the necessary marketing authorizations from the President of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products (URPLWMiPB). Products must also meet Good Manufacturing Practice (GMP) standards, as verified by the Chief Pharmaceutical Inspectorate. Additionally, labeling requirements include providing information in Polish, detailing the product's composition, dosage instructions, and any necessary warnings. Compliance with these standards is essential for successful market entry. (kpk.nfz.gov.pl)

Frequently Asked Questions — SVS Management Ltd

What products does SVS Management Ltd import from India?

SVS Management Ltd imports 2 pharmaceutical products across 1 categories. Top imports: Gutika ($6.2K), Ghrita ($2.6K).

Who supplies pharmaceuticals to SVS Management Ltd from India?

SVS Management Ltd sources from 3 verified Indian suppliers. The primary supplier is Shri Dharmasthala Manjunatheshwara Baishajya Prati (48.7% of imports, $45.2K).

What is SVS Management Ltd's total pharmaceutical import value?

SVS Management Ltd's total pharmaceutical import value from India is $8.7K, based on 13 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does SVS Management Ltd focus on?

SVS Management Ltd imports across 1 categories. The largest: Ayurvedic & Herbal Products (100.0%).

Get Full SVS Management Ltd Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.